Ankur Dhingra, Chief Financial Officer at Summit Therapeutics Inc. (SMMT), bought 20,400 shares at $2.15 ($44K) on 2023-12-13, disclosed to the SEC on 2023-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 700 | $2K | 3.4% |
| 2 | $2.17 | 19,700 | $43K | 96.6% |
| Total | $2.17 avg | 20,400 | $44K | 100% |
| Filing → |
| SMMT | BUY | 2023-03-08 | $13K | — | Filing → |
| SMMT | BUY | 2023-03-08 | $412K | — | Filing → |
| SMMT | BUY | 2022-08-17 | $35K | — | Filing → |